Kettering Health Network   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Dayton OH United States (1999)

Organization Overview

First Clinical Trial
2005
NCT00712270
First Marketed Drug
2015
fludeoxyglucose f-18
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Harvey Hahn | Kettering Health Network | KETTERING MEDCTR